全身型重症肌无力合并新型冠状病毒肺炎患者的管理：4例病例报告 - Suppr

Suppr

超能文献

Management of patients with generalised myasthenia gravis and COVID-19: four case reports.

作者信息

Hübers Annemarie, Lascano Agustina M, Lalive Patrice H

机构信息

Department of Clinical Neurosciences, University Hospitals Geneva, Geneve, Switzerland

Division of Neurology, University Hospitals of Geneva, Geneva, Switzerland.

出版信息

J Neurol Neurosurg Psychiatry. 2020 Oct;91(10):1124-1125. doi: 10.1136/jnnp-2020-323565. Epub 2020 Jul 10.

DOI:10.1136/jnnp-2020-323565

PMID:32651248

Abstract

摘要

相似文献

Management of patients with generalised myasthenia gravis and COVID-19: four case reports.

J Neurol Neurosurg Psychiatry. 2020 Oct;91(10):1124-1125. doi: 10.1136/jnnp-2020-323565. Epub 2020 Jul 10.

Myasthenic crisis in COVID-19.

J Neurol Sci. 2020 Jul 15;414:116888. doi: 10.1016/j.jns.2020.116888. Epub 2020 May 6.

Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic.

J Neurol Sci. 2020 May 15;412:116803. doi: 10.1016/j.jns.2020.116803. Epub 2020 Mar 25.

Speculative clues on Myasthenia gravis and COVID-19.

Eur Rev Med Pharmacol Sci. 2020 Aug;24(15):7925-7926. doi: 10.26355/eurrev_202008_22474.

Reply from the authors: Myasthenic crises in COVID-19.

J Neurol Sci. 2020 Oct 15;417:117061. doi: 10.1016/j.jns.2020.117061. Epub 2020 Jul 27.

Immunocompromised myasthenia gravis patient not infected with SARS-CoV-2 after close exposure - what is the risk of COVID-19?

Neurol Neurochir Pol. 2020;54(5):481-482. doi: 10.5603/PJNNS.a2020.0072. Epub 2020 Oct 2.

Diagnosing myasthenic crisis in SARS-CoV-2 infected patients requires adherence to appropriate criteria.

J Neurol Sci. 2020 Oct 15;417:117062. doi: 10.1016/j.jns.2020.117062. Epub 2020 Jul 27.

Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19.

J Neurol Sci. 2020 Nov 15;418:117106. doi: 10.1016/j.jns.2020.117106. Epub 2020 Sep 2.

Clinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection.

Neurology. 2020 Nov 3;95(18):840-843. doi: 10.1212/WNL.0000000000010651. Epub 2020 Aug 14.

COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome.

J Neuromuscul Dis. 2020;7(3):361-364. doi: 10.3233/JND-200520.

引用本文的文献

Seronegative Myasthenia Gravis: A Rare Disease Triggered by SARS-CoV-2 or a Coincidence?

Cureus. 2024 Aug 22;16(8):e67511. doi: 10.7759/cureus.67511. eCollection 2024 Aug.

Neurological complications caused by SARS-CoV-2.

Clin Microbiol Rev. 2024 Dec 10;37(4):e0013124. doi: 10.1128/cmr.00131-24. Epub 2024 Sep 18.

Myasthenia Gravis and COVID-19: A Systematic Review and Meta-analysis.

Basic Clin Neurosci. 2024 Mar-Apr;15(2):175-184. doi: 10.32598/bcn.2023.4360.5. Epub 2024 Mar 1.

Long COVID as a Tauopathy: Of "Brain Fog" and "Fusogen Storms".

Int J Mol Sci. 2023 Aug 10;24(16):12648. doi: 10.3390/ijms241612648.

COVID-19-Related Left-Sided Ptosis.

Cureus. 2023 Jul 8;15(7):e41574. doi: 10.7759/cureus.41574. eCollection 2023 Jul.

COVID-19 and myasthenia gravis: A review of neurological implications of the SARS-COV-2.

Brain Behav. 2022 Dec;12(12):e2789. doi: 10.1002/brb3.2789. Epub 2022 Oct 28.

Manifestation of Ocular Myasthenia Gravis as an Initial Symptom of Coronavirus Disease 2019: A Case Report.

Iran J Med Sci. 2022 Jul;47(4):385-388. doi: 10.30476/IJMS.2021.89841.2061.

Acute neuromuscular syndromes with respiratory failure during COVID-19 pandemic: Where we stand and challenges ahead.

J Clin Neurosci. 2022 Jul;101:264-275. doi: 10.1016/j.jocn.2022.03.048. Epub 2022 Apr 29.

Multisystem Inflammatory Syndrome and Autoimmune Diseases Following COVID-19: Molecular Mechanisms and Therapeutic Opportunities.

Front Mol Biosci. 2022 Apr 14;9:804109. doi: 10.3389/fmolb.2022.804109. eCollection 2022.

Myasthenia Gravis and COVID-19 - A Clinical Checkmate.

Anesth Essays Res. 2021 Oct-Dec;15(4):457-459. doi: 10.4103/aer.aer_129_21. Epub 2022 Mar 8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Management of patients with generalised myasthenia gravis and COVID-19: four case reports.

J Neurol Neurosurg Psychiatry. 2020 Oct;91(10):1124-1125. doi: 10.1136/jnnp-2020-323565. Epub 2020 Jul 10.

Myasthenic crisis in COVID-19.

J Neurol Sci. 2020 Jul 15;414:116888. doi: 10.1016/j.jns.2020.116888. Epub 2020 May 6.

Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic.

J Neurol Sci. 2020 May 15;412:116803. doi: 10.1016/j.jns.2020.116803. Epub 2020 Mar 25.

Speculative clues on Myasthenia gravis and COVID-19.

Eur Rev Med Pharmacol Sci. 2020 Aug;24(15):7925-7926. doi: 10.26355/eurrev_202008_22474.

Reply from the authors: Myasthenic crises in COVID-19.

J Neurol Sci. 2020 Oct 15;417:117061. doi: 10.1016/j.jns.2020.117061. Epub 2020 Jul 27.

Immunocompromised myasthenia gravis patient not infected with SARS-CoV-2 after close exposure - what is the risk of COVID-19?

Neurol Neurochir Pol. 2020;54(5):481-482. doi: 10.5603/PJNNS.a2020.0072. Epub 2020 Oct 2.

Diagnosing myasthenic crisis in SARS-CoV-2 infected patients requires adherence to appropriate criteria.

J Neurol Sci. 2020 Oct 15;417:117062. doi: 10.1016/j.jns.2020.117062. Epub 2020 Jul 27.

Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19.

J Neurol Sci. 2020 Nov 15;418:117106. doi: 10.1016/j.jns.2020.117106. Epub 2020 Sep 2.

Clinical Reasoning: Therapeutic considerations in myasthenic crisis due to COVID-19 infection.

Neurology. 2020 Nov 3;95(18):840-843. doi: 10.1212/WNL.0000000000010651. Epub 2020 Aug 14.

COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome.

J Neuromuscul Dis. 2020;7(3):361-364. doi: 10.3233/JND-200520.

引用本文的文献

Seronegative Myasthenia Gravis: A Rare Disease Triggered by SARS-CoV-2 or a Coincidence?

Cureus. 2024 Aug 22;16(8):e67511. doi: 10.7759/cureus.67511. eCollection 2024 Aug.

Neurological complications caused by SARS-CoV-2.

Clin Microbiol Rev. 2024 Dec 10;37(4):e0013124. doi: 10.1128/cmr.00131-24. Epub 2024 Sep 18.

Myasthenia Gravis and COVID-19: A Systematic Review and Meta-analysis.

Basic Clin Neurosci. 2024 Mar-Apr;15(2):175-184. doi: 10.32598/bcn.2023.4360.5. Epub 2024 Mar 1.

Long COVID as a Tauopathy: Of "Brain Fog" and "Fusogen Storms".

Int J Mol Sci. 2023 Aug 10;24(16):12648. doi: 10.3390/ijms241612648.

COVID-19-Related Left-Sided Ptosis.

Cureus. 2023 Jul 8;15(7):e41574. doi: 10.7759/cureus.41574. eCollection 2023 Jul.

COVID-19 and myasthenia gravis: A review of neurological implications of the SARS-COV-2.

Brain Behav. 2022 Dec;12(12):e2789. doi: 10.1002/brb3.2789. Epub 2022 Oct 28.

Manifestation of Ocular Myasthenia Gravis as an Initial Symptom of Coronavirus Disease 2019: A Case Report.

Iran J Med Sci. 2022 Jul;47(4):385-388. doi: 10.30476/IJMS.2021.89841.2061.

Acute neuromuscular syndromes with respiratory failure during COVID-19 pandemic: Where we stand and challenges ahead.

J Clin Neurosci. 2022 Jul;101:264-275. doi: 10.1016/j.jocn.2022.03.048. Epub 2022 Apr 29.

Multisystem Inflammatory Syndrome and Autoimmune Diseases Following COVID-19: Molecular Mechanisms and Therapeutic Opportunities.

Front Mol Biosci. 2022 Apr 14;9:804109. doi: 10.3389/fmolb.2022.804109. eCollection 2022.

Myasthenia Gravis and COVID-19 - A Clinical Checkmate.

Anesth Essays Res. 2021 Oct-Dec;15(4):457-459. doi: 10.4103/aer.aer_129_21. Epub 2022 Mar 8.